156 related articles for article (PubMed ID: 6317239)
41. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
42. Autoantibodies against histones and actin in patients with rheumatic diseases assessed by the western blot method.
Raska I; Petrasovicová V; Jarník M; Cebecauser L; Lukacovicová L; Lejnar J; Viklický V; Mácha J; Jíra M; Trnavský K
Czech Med; 1991; 14(3):135-45. PubMed ID: 1807931
[TBL] [Abstract][Full Text] [Related]
43. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.
Favrot MC; Philip I; Philip T; Portoukalian J; Doré JF; Lenoir GM
J Natl Cancer Inst; 1984 Oct; 73(4):841-7. PubMed ID: 6592381
[TBL] [Abstract][Full Text] [Related]
44. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
45. Definition of normal autoantibody levels in an apparently healthy population.
el-Roeiy A; Gleicher N
Obstet Gynecol; 1988 Oct; 72(4):596-602. PubMed ID: 3262207
[TBL] [Abstract][Full Text] [Related]
46. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
47. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
48. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection.
Boonpucknavig S; Ekapanyakul G
Clin Exp Immunol; 1984 Oct; 58(1):77-82. PubMed ID: 6383670
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
50. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies.
Biggar RJ; Nkrumah FK; Henle W; Levine PH
J Natl Cancer Inst; 1981 Mar; 66(3):439-44. PubMed ID: 6259398
[TBL] [Abstract][Full Text] [Related]
51. Current investigations and treatment of Burkitt's lymphoma in Africa.
Orem J; Mbidde EK; Weiderpass E
Trop Doct; 2008 Jan; 38(1):7-11. PubMed ID: 18302850
[TBL] [Abstract][Full Text] [Related]
52. The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.
Lachmann PJ; Macanovic M; Harkiss GD; Oldroyd RG; Habicht J
Clin Exp Immunol; 1981 Nov; 46(2):250-8. PubMed ID: 6279342
[TBL] [Abstract][Full Text] [Related]
53. Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa.
Biggar RJ; Gardiner C; Lennette ET; Collins WE; Nkrumah FK; Henle W
Lancet; 1981 Jul; 2(8238):115-8. PubMed ID: 6113482
[TBL] [Abstract][Full Text] [Related]
54. Cerebrospinal fluid markers in African Burkitt's lymphoma with central nervous system involvement.
Wallen WC; Biggar RJ; Levine PH; Neequaye J; Nkrumah FK
J Natl Cancer Inst; 1982 Oct; 69(4):787-92. PubMed ID: 6288991
[TBL] [Abstract][Full Text] [Related]
55. Burkitt's and other non-Hodgkin's lymphomas in adults exposed to a visitor from Africa.
Grufferman S; Raab-Traub N; Marvin K; Borowitz MJ; Pagano JS
N Engl J Med; 1985 Dec; 313(24):1525-9. PubMed ID: 2999593
[No Abstract] [Full Text] [Related]
56. Letter: E.B. virus and American and African Burkitt's lymphoma.
Levine PH; O'Conor G
Lancet; 1973 Oct; 2(7833):850. PubMed ID: 4126648
[No Abstract] [Full Text] [Related]
57. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
Morgan AJ; Finerty S; Lovgren K; Scullion FT; Morein B
J Gen Virol; 1988 Aug; 69 ( Pt 8)():2093-6. PubMed ID: 2841417
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a novel Burkitt's lymphoma-associated antigen: GP70. Reactivity of anti-GP70 antibodies with various malignant and non-malignant cell lines.
Gazitt Y; Lerner A; Ben-Bassat H
Immunol Lett; 1986 Jan; 12(1):43-50. PubMed ID: 3007337
[TBL] [Abstract][Full Text] [Related]
59. Update on laboratory studies and relationship to rheumatic and allergic diseases.
McCarty GA
Ann Allergy; 1985 Sep; 55(3):421-33. PubMed ID: 2412470
[TBL] [Abstract][Full Text] [Related]
60. A case of Burkitt's lymphoma presenting with digital ischaemia.
Smith P; Rice M; Ricci N; Toogood I; Roberton D
Acta Paediatr; 1993 Feb; 82(2):217-9. PubMed ID: 8477174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
